Phio Pharmaceuticals Corp (PHIO) Stock Price

1.285 ▲ +0.165 (+14.73%)
Open: 1.28 Vol: 63.92K Day's range: 1.19 - 1.42 Feb 11, 15:59 EST
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
PHIO Technical Analysis
5 mins 30 mins Hourly Daily Weekly
BUY BUY BUY BUY SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 1.29▼ 1.29▼ 1.28▲ 1.02▲ 1.09▲
MA10 1.28▲ 1.26▲ 1.25▲ 1.00▲ 1.10▲
MA20 1.28▲ 1.26▲ 1.16▲ 1.04▲ 1.42▼
MA50 1.25▲ 1.09▲ 1.02▲ 1.10▲ 1.79▼
MA100 1.26▲ 1.03▲ 1.03▲ 1.50▼ 2.84▼
MA200 1.16▲ 1.06▲ 1.07▲ 1.85▼ 22.25▼
  5 mins 30 mins Hourly Daily Weekly
MACD 0.000▲ -0.008▼ 0.007▲ 0.025▲ 0.005▲
RSI 54.064▲ 56.496▲ 60.355▲ 65.631▲ 44.534▼
STOCH 66.667     59.893     47.563     36.578     28.945    
WILL %R -33.333     -45.000     -52.857     -29.222     -42.911    
CCI 68.750     30.075     14.602     217.816▲ 50.055    
Latest Filters Detected On PHIO
▲ GAP $PHIO Open Gap Up %5 Set Alert
▲ GAP $PHIO Open Gap Up %3 Set Alert
▲ GAP $PHIO Open Gap Up %2 Set Alert
CDL $PHIO Harami Candlestick Pattern Detected Set Alert
CDL $PHIO Doji Candlestick Pattern Detected Set Alert
Phio Pharmaceuticals Corp News
Cancer Biotech Phio Pharmaceuticals Stock Surges As Trial Shows Tumor Clearance At Highest Dose In Skin Cancer Patients
Tuesday, February 10, 2026 07:12 AM
Phio Pharmaceuticals shares rise after Phase 1b data shows strong safety and tumor clearance for its PH-762 skin cancer drug, with FDA talks planned in 2026.
Phio Pharmaceuticals stock soars after strong cancer treatment results
Tuesday, February 10, 2026 06:45 AM
The clinical-stage siRNA biopharmaceutical company announced that its INTASYL compound PH-762 achieved an 85% pathological response rate in the final cohort, with 6 of 7 patients responding to ...
Phio Announces Safety Monitoring Committee's (SMC) Positive Wrap-up on Lead Clinical Candidate PH-762 in Skin Cancer Trial
Tuesday, February 10, 2026 04:18 AM
Maximum Dose Concentration in Final Cohort Yields 85% Pathological Response (6 of 7 Patients); Complete Response (100% Tumor Clearance) in 4 of 6 RespondersNo Serious Adverse Events or Dose-Limiting ...
PHIO historical stock data
date open high low close volume
11/02/26 1.28 1.42 1.19 1.285 15,113,661
10/02/26 1.41 1.48 1.12 1.12 162,698,240
09/02/26 0.93 0.93 0.8805 0.90 102,420
06/02/26 0.84 0.9299 0.84 0.9201 123,558
05/02/26 0.91 0.916 0.8127 0.8568 423,400
04/02/26 0.98 0.98 0.9142 0.925 318,958
03/02/26 0.98 0.9997 0.9402 0.9786 171,983
02/02/26 1.00 1.0055 0.97 0.9871 285,404
30/01/26 1.02 1.02 1.00 1.01 240,058
29/01/26 1.03 1.03 1.00 1.02 189,388
Quote Details
52wk Low:0.813
52wk High:4.19
Vol:63.92K
Avg Vol(3m):64.9M
1Y Chng:-9.51%
1M Chng:+25.98%
Add to Watch List
More Information
Index US Composite
Market Cap. 15.79M